These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3100716)

  • 1. Effects of different methods of purification on aggregation of scrapie infectivity.
    Castle BE; Dees C; German TL; Marsh RF
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():225-31. PubMed ID: 3100716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium density gradient centrifugation of the scrapie agent in Nycodenz.
    Marsh RF; Castle BE; Dees C; Wade WF
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1963-8. PubMed ID: 6438273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the scrapie agent by density gradient centrifugation.
    Marsh RF; Dees C; Castle BE; Wade WF; German TL
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():415-21. PubMed ID: 6420511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered scrapie infectivity estimates by titration and incubation period in the presence of detergents.
    Somerville RA; Carp RI
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2045-50. PubMed ID: 6411862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis.
    Brown P; Liberski PP; Wolff A; Gajdusek DC
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7240-4. PubMed ID: 2119503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the scrapie agent in a scaled-down procedure for the purification of gangliosides from brain tissue.
    Di Martino A; Safar J; Ceroni M; Gibbs CJ
    Dev Biol Stand; 1993; 80():187-94. PubMed ID: 8270108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of a short incubation model of scrapie in the golden hamster.
    Kimberlin RH; Walker C
    J Gen Virol; 1977 Feb; 34(2):295-304. PubMed ID: 402439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.
    Prusiner SB; Groth DF; Cochran SP; Masiarz FR; McKinley MP; Martinez HM
    Biochemistry; 1980 Oct; 19(21):4883-91. PubMed ID: 6775697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards purification of the scrapie agent.
    Diringer H; Hilmert H; Simon D; Werner E; Ehlers B
    Eur J Biochem; 1983 Aug; 134(3):555-60. PubMed ID: 6411468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of proteins in membrane vesicles from scrapie-infected hamster brain.
    Dees C; German TL; Wade WF; Marsh RF
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():851-9. PubMed ID: 3920349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally.
    Czub M; Braig HR; Diringer H
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():2005-9. PubMed ID: 2875123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue.
    Di Martino A; Safar J; Ceroni M; Gibbs CJ
    Arch Virol; 1992; 124(1-2):111-21. PubMed ID: 1571012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempts to restore scrapie prion infectivity after exposure to protein denaturants.
    Prusiner SB; Groth D; Serban A; Stahl N; Gabizon R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2793-7. PubMed ID: 8464892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the scrapie agent by pronase.
    Cho HJ
    Can J Comp Med; 1983 Oct; 47(4):494-6. PubMed ID: 6230145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copurification of Sp33-37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease.
    Bolton DC; Rudelli RD; Currie JR; Bendheim PE
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():2905-13. PubMed ID: 1684986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of scrapie agent from infected animal brains and raising of antibodies to the purified fraction.
    Takahashi K; Shinagawa M; Doi S; Sasaki S; Goto H; Sato G
    Microbiol Immunol; 1986; 30(2):123-31. PubMed ID: 3086675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of prion rods purified from scrapie-infected hamster brains.
    McKinley MP; Braunfeld MB; Bellinger CG; Prusiner SB
    J Infect Dis; 1986 Jul; 154(1):110-20. PubMed ID: 2872252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
    Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification of the scrapie agent from mouse brain by pressure disruption and zonal centrifugation in sucrose-sodium chloride gradients.
    Siakotos AN; Gajdusek DC; Gibbs CJ; Traub RD; Bucana C
    Virology; 1976 Mar; 70(1):230-7. PubMed ID: 816078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.